Zakikhani et al reported that metformin inhibited the growth of breast cancer cells through the activation of AMPK and the inhibition of Akt to suppress certain regulatory molecules, including mTOR and S6 kinase (S6K) (14). Here, RPS6KB1 is linked to breast cancer.